Journal of Surgical Research
Volume 162, Issue 1 , Pages 17-21 , July 2010

Use of Statins in Adhesive Small Bowel Obstruction1

  • Sanket Srinivasa, M.B.Ch.B.

      Affiliations

    • Department of Surgery, South Auckland Clinical School, University of Auckland, Auckland, New Zealand
    • These authors are recipients of the Auckland Medical Research Foundation (AMRF) Ruth Spencer Medical Research Fellowship.
    • ,
  • Arman A. Kahokehr, B.H.B., M.B.Ch.B.

      Affiliations

    • Department of Surgery, South Auckland Clinical School, University of Auckland, Auckland, New Zealand
    • These authors are recipients of the Auckland Medical Research Foundation (AMRF) Ruth Spencer Medical Research Fellowship.
    • ,
  • Tarik Sammour, B.H.B., M.B.Ch.B.

      Affiliations

    • Department of Surgery, South Auckland Clinical School, University of Auckland, Auckland, New Zealand
    • Recipient of the Royal Australasian College of Surgeons (RACS) Surgeon Scientist Scholarship.
    • ,
  • Tzu-Chieh Yu, B.H.B., M.B.Ch.B.

      Affiliations

    • Department of Surgery, South Auckland Clinical School, University of Auckland, Auckland, New Zealand
    • ,
  • Saleh M. Abbas, M.B.B.S., F.R.A.C.S.

      Affiliations

    • Department of Surgery, Middlemore Hospital, University of Auckland, Auckland, New Zealand
    • ,
  • Andrew G. Hill, M.D., F.R.A.C.S.

      Affiliations

    • Department of Surgery, South Auckland Clinical School, University of Auckland, Auckland, New Zealand
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Surgery, Middlemore Hospital, University of Auckland, P.O. Box 93311 Otahuhu, Auckland, New Zealand.

Received 14 December 2009

References 

  1. Cox MR, Gunn IF, Eastman MC, et al. The operative aetiology and types of adhesions causing small bowel obstruction. ANZ J Surg. 1993;63:848
  2. Miller G, Boman J, Shrier I, et al. Etiology of small bowel obstruction. Am J Surg. 2000;180:33
  3. Menzies D, Parker M, Hoare R, et al. Small bowel obstruction due to postoperative adhesions: Treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl. 2001;83:40
  4. Fevang BT, Fevang J, Lie SA, et al. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg. 2004;240:193
  5. Attard JA, MacLean AR. Adhesive small bowel obstruction: Epidemiology, biology and prevention. Can J Surg. 2007;50:291
  6. Aarons CB, Cohen PA, Gower A, et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg. 2007;245:176
  7. Kucuk HF, Kaptanoglu L, Kurt N, et al. The role of simvastatin on postoperative peritoneal adhesion formation in an animal model. Eur Surg Res. 2007;39:98
  8. Dotani MI, Elnicki DM, Jain AC, et al. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol. 2000;86:1128
  9. Dotani MI, Morise AP, Haque R, et al. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol. 2003;91:1107
  10. Pan W, Pintar T, Anton J, et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110(11 Suppl. 1):II45
  11. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial. J Vasc Surg. 2004;39:967;discussion 75
  12. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848
  13. Kennedy J, Quan H, Buchan AM, et al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005;36:2072
  14. Eto MLT. Modulation of coagulation and fibrinolytic pathways by statins. Endothelium. 2003;10:35
  15. Mason JC. Statins and their role in vascular protection. Clin Sci. 2003;105:251
  16. Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol. 2003;23:729
  17. Durant R, Klouche K, Delbosc S, et al. Superoxide anion overproduction in sepsis: Effects of vitamin e and simvastatin. Shock. 2004;22:34
  18. Van der Wal JB, Jeekel J. The use of statins in postoperative adhesion prevention. Ann Surg. 2007;245:185
  19. Terblanche M, Almog Y, Rosenson RS, et al. Statins: Panacea for sepsis?. Lancet Infect Dis. 2006;6:242
  20. Spitzer AL, Harris HW. Statins attenuate sepsis. Surgery. 2006;139:283
  21. Merx MW, Weber C. Statins in the intensive care unit. Curr Opin Crit Care. 2006;12:309
  22. Sihler KC, Baser O, Birkmeyer NJ, et al. Statin use reduces the risk of postoperative infections and respiratory complications from non-cardiac general surgery. J Surg Res. 2009;151:176
  23. Heydrick SJ, Reed KL, Cohen PA, et al. Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation. J Surg Res. 2007;143:311
  24. Naito Y, Katada K, Takagi T, et al. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein. World J Gastroenterol. 2006;12:2024
  25. Nakagawa H, Tsunooka N, Yamamoto Y, et al. Pitavastatin prevents intestinal ischemia/reperfusion-induced bacterial translocation and lung injury in atherosclerotic rats with hypoadiponectinemia. Surgery. 2009;145:542
  26. Tsunooka N, Nakagawa H, Doi T, et al. Pitavastatin prevents bacterial translocation after nonpulsatile/low-pressure blood flow in early atherosclerotic rat: Inhibition of small intestine inducible nitric oxide synthase. Eur Surg Res. 2005;37:302
  27. Srinivasa S, Thakore N, Abbas S, et al. Clinical impact of gastrografin protocol in a tertiary hospital. Can J Surg. 2010;(in press)
  28. Fazio V, Cohen Z, Fleshman J, et al. Reduction in adhesive small-bowel obstruction by seprafilm adhesion barrier after intestinal resection. Dis Col Rect. 2006;49:1
  29. Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281
  30. Haslinger B, Goedde MF, Toet KH, et al. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney Int. 2002;62:1611
  31. Haslinger B, Kleemann R, Toet KH, et al. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-α-activated human peritoneal mesothelial cells. Kidney Int. 2003;63:2065
  32. Brookes ZL, McGown CC, Reilly CS. Statins for all: The new premed?. Br J Anaesth. 2009;103:99
  33. Waisman D, Brod V, Wolff R, et al. Effects of hyperoxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2003;285:H643
  34. Cueva JP, Hsueh W. Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. Gut. 1988;29:1207
  35. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res. 2000;49:497
  36. Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.[Erratum appears in Circulation. 2003;108:2170]. Circulation. 2003;108:839
  37. Danesh FR, Anel RL, Zeng L, et al. Immunomodulatory effects of HMG-CoA reductase inhibitors. Arch Immunol Ther Exp (Warsz). 2003;51:139
  38. Fischetti F, Carretta R, Borotto G, et al. Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin Exp Immunol. 2004;135:186
  39. Ozacmak VH, Sayan H, Igdem AA, et al. Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats. Eur J Pharmacol. 2007;562:138
  40. Merx MW, Liehn EA, Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation. 2004;109:2560
  41. Sasaki M, Bharwani S, Jordan P, et al. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis. J Pharmacol Exp Ther. 2003;305:78
  42. Xie XQ, Shinozawa Y, Sasaki J, et al. The effects of arginine and selective inducible nitric oxide synthase inhibitor on pathophysiology of sepsis in a CLP model. J Surg Res. 2008;146:298
  43. Effect of rosuvastatin in abdominal sepsis. Clinical trials identifier NCT 00357123. Avaialble at: http://clinicaltrials.gov/ct2/show/NCT00357123. Accessed October 17, 2009.
  44. Ma JSN, Ayanian JZ, Stafford RS. National trends in statin use by coronary heart disease risk category. PLoS Med. 2005;2:e123
  45. Sagar P, Hartley M, Mancey-Jones B, et al. Comparative audit of colorectal resection with the POSSUM scoring system. Br J Surg. 1994;81:1492

PII: S0022-4804(10)00156-3

doi: 10.1016/j.jss.2010.02.028

Journal of Surgical Research
Volume 162, Issue 1 , Pages 17-21 , July 2010

Article Tools